Suchergebnisse

Abstract. A precipitation event of unprecedented intensity took place over northern part of Israel during 4 December 2001–5 December 2001. The case was associated with formation of a Cyprus Low cyclone over the Asia Minor. In the current study the synoptic developments over the eastern part of the Mediterranean region are simulated with the MM5 nonhydrostatic model and analyzed based on dynamic tropopause patterns calculated from the simulation results. According to the results, a powerful potential vorticity (PV) streamer system played a major role in the process over the southeastern Mediterranean region. The PV streamer created conditions for seclusion of moist air masses from the equatorial East Africa and Atlantics during the cyclone development. Condensation of the moisture, associated with the latent heat release processes have contributed to the intense thunderstorm activity and heavy precipitation of the event.

According to the political perspective on strategic decision making, political decisions are the results of a process in which the preferences of the most powerful dominate over those of the less powerful. The conceptualization of political behavior accounts for issues, such as negotiation, bargaining, and power, which are central to this perspective. Since strategic decisions during the new product development (NPD) process are made by team members, they are a mass of action, interaction, and counteraction. This means that the strategic decision-making process during NPD can be subject to political behavior. This study extends research on political behavior into the realm of NPD teams by examining the impact of six contextual variables (project importance, project uncertainty, project motive, trust, functional diversity, and demographic diversity) associated with two types of context (project and team environment) on the practice of political behavior in NPD teams. The study also examines the impact of political behavior on speed to market considering the moderating impact of environmental turbulence. Using primary and cross-sectional data obtained from 103 Turkish NPD teams, our results showed that project importance, project motive, and functional diversity significantly influence political behavior. Interestingly, our results indicated that political behavior positively influences speed to market. We present and discuss our empirical results, provide implications for both theory and practice, and discuss research limitations.

While policy attention is understandably diverted to COVID-19, the end of the UK's post-Brexit 'transition period' remains 31 December 2020. All forms of future EU−UK relationship are worse for health than EU membership, but analysis of the negotiating texts shows some forms are better than others. The likely outcomes involve major negative effects for NHS staffing, funding for health and social care, and capital financing for the NHS; and for UK global leadership and influence. We expect minor negative effects for cross border healthcare (except in Northern Ireland); research collaboration; and data sharing, such as the Early Warning and Response System for health threats. Despite political narratives, the legal texts show that the UK seeks de facto continuity in selected key areas for pharmaceuticals, medical devices, and equipment [including personal protective equipment (PPE)], especially clinical trials, pharmacovigilance, and batch-testing. The UK will be excluded from economies of scale of EU membership, e.g. joint procurement programmes as used recently for PPE. Above all, there is a major risk of reaching an agreement with significant adverse effects for health, without meaningful oversight by or input from the UK Parliament, or other health policy stakeholders.

While policy attention is understandably diverted to COVID-19, the end of the UK's post-Brexit 'transition period' remains 31 December 2020. All forms of future EU−UK relationship are worse for health than EU membership, but analysis of the negotiating texts shows some forms are better than others. The likely outcomes involve major negative effects for NHS staffing, funding for health and social care, and capital financing for the NHS; and for UK global leadership and influence. We expect minor negative effects for cross border healthcare (except in Northern Ireland); research collaboration; and data sharing, such as the Early Warning and Response System for health threats. Despite political narratives, the legal texts show that the UK seeks de facto continuity in selected key areas for pharmaceuticals, medical devices, and equipment [including personal protective equipment (PPE)], especially clinical trials, pharmacovigilance, and batch-testing. The UK will be excluded from economies of scale of EU membership, e.g. joint procurement programmes as used recently for PPE. Above all, there is a major risk of reaching an agreement with significant adverse effects for health, without meaningful oversight by or input from the UK Parliament, or other health policy stakeholders.

The UK's relationship with the European Union (EU) is now embodied in two principal legal instruments: the EU–UK Trade and Cooperation Agreement, which formally entered into force on 1 May 2021; and the Withdrawal Agreement, with its Protocol on Ireland/Northern Ireland, which continues to apply. Using a 'building blocks' framework for analysis of national health systems derived from the World Health Organisation, this article examines the likely impacts in the UK of this legal settlement on the National Health Service (NHS), health and social care. Specifically, we determine the extent to which the trade, cooperation and regulatory aspects of those legal measures support positive impacts for the NHS and social care. We show that, as there is clear support for positive health and care outcomes in only one of the 17 NHS 'building blocks', unless mitigating action is taken, the likely outcomes will be detrimental. However, as the legal settlement gives the UK a great deal of regulatory freedom, especially in Great Britain, we argue that it is crucial to track the effects of proposed new health and social care-related policy choices in the months and years ahead.